The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).
 
Akihiko Murata
Research Funding - Taiho Pharmaceutical (Inst)
 
Kazuhiro Yoshida
No Relationships to Disclose
 
Kiyoshi Maeda
No Relationships to Disclose
 
Koji Ikejiri
No Relationships to Disclose
 
Yoshinori Munemoto
No Relationships to Disclose
 
Kazuaki Sasaki
No Relationships to Disclose
 
Chu Matsuda
No Relationships to Disclose
 
Masanori Kotake
No Relationships to Disclose
 
Toyokuni Suenaga
No Relationships to Disclose
 
Hiroyuki Matsuda
No Relationships to Disclose
 
Hideo Baba
Speakers' Bureau - Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Chikuma Hamada
Consulting or Advisory Role - Taiho Pharmaceutical
 
Eiji Oki
No Relationships to Disclose
 
Yasunori Emi
No Relationships to Disclose
 
Shigetoyo Saji
No Relationships to Disclose
 
Yoshihiko Maehara
Research Funding - Chugai Pharma (Inst); Merck Serono (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)